Clinical Trials · NCT07136714

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

Name: Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

RecruitingPhase 4Semaglutide

Phase: Phase 4
Recruitment status: Recruiting
Sponsor: Nordsjaellands Hospital
Enrollment: 116
Start date: Sep 2025
Locations: 1 site, Denmark
Primary endpoint: Change in depressive symptoms

View Semaglutide compound reference